Brain pacemaker showdown: which target best eases Parkinson's symptoms?
NCT ID NCT07250685
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two brain areas for deep brain stimulation (DBS) in 86 people with Parkinson's disease. The goal is to see which target—the subthalamic nucleus (STN) or the globus pallidus internus (GPi)—better improves movement symptoms 90 days after surgery. Participants will be randomly assigned to one target and then switch to the other, with doctors and patients unaware of which is active.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PD - PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tiantan Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, 100070, China
-
Changhai Hospital of Shanghai
Shanghai, Shanghai Municipality, 200120, China
-
Nanjing Brain Hospital
Nanjing, Jiangsu, 210029, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
-
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, 116011, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, 300350, China
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.